Manufacturer record
LV life Sciences VPO Gurumajra: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by LV life Sciences VPO Gurumajra (Himachal Pradesh) was declared Not of Standard Quality in May 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: LV23HT-034B, Rabedin tablet Tablets, Rabeprazole Sodium Gastro-Resistant Tabelts IP, (exp Jan 2025). State Lab Drugs Control Laboratory, Telangana (state lab) found it not of standard quality: NOT OF STANDARD QUALITY The sample does not meet the acid stage acceptance criteria as per IP specifications, hence it is declared as NOT OF. Listed in the May 2024 alert.
Records by type
1 record linked to LV life Sciences VPO Gurumajra in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabedin tablet Tablets, Rabeprazole Sodium Gastro-Resistant Tabelts IP, | Batch LV23HT-034BMfg Aug 2023 · Exp Jan 2025 | NOT OF STANDARD QUALITY The sample does not meet the acid stage acceptance criteria as per IP specifications, hence it is declared as NOT OF STANDARD QUALITY.Other | State Lab Drugs Control Laboratory, TelanganaState lab | May 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.